A Novel Target and Biological Therapeutics for Conditions Involving Neovascularization and Fibrosis - Two Programs

1: DARETherapeutics program - novel biologics for treatment of nAMD and DME/DR related blindness. 2: treating fibrosis in liver, kidney, gut

Intellectual property rights are held by University of Southern Denmark : US9,988,442 and EP14743707.3 and WO2019086580 and PCT/EP2022/059600